Sign in

CIK 0000034956 · Non-accelerated filer<br>Smaller reporting company

TENAX THERAPEUTICS, INC.

Sign in to watch
Ticker
TENX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
262593535
Phone
919-855-2100
Business address
101 GLEN LENNOX DRIVE, SUITE 300, CHAPEL HILL, NC, 27517
Former names
OXYGEN BIOTHERAPEUTICS, INC., SYNTHETIC BLOOD INTERNATIONAL INC
  1. 4 Option exercise Director acquired 3,070,000 shares (option exercise)
  2. 4 Grant or award Director acquired 512,000 shares (grant or award)
  3. 3 Insider Initial Statement of Ownership
  4. 3 Insider Initial Statement of Ownership
  5. 8-K Event Shareholder vote results · Other events
  6. 8-K Event Agreement ended
  7. 10-Q Report Quarterly Report
  8. DEF 14A Proxy Proxy Statement
  9. PRE 14A Proxy Proxy Statement (Preliminary)
  10. 10-K/A Report 10-K/A
  11. 8-K Event Executive or director change
  12. 10-K Report Annual Report
  13. 8-K/A Event Exhibits
  14. SEC STAFF LETTER Other SEC Staff Letter Redacted Exhibit
  15. 8-K Event Executive or director change
  16. SEC STAFF LETTER Other SEC Staff Letter Redacted Exhibit
  17. SC 13G/A Stake Amended Statement of Ownership
  18. SC 13G/A Stake Amended Statement of Ownership
  19. 4 Grant or award Chief Medical Officer acquired 666,098 shares (grant or award)
  20. 3 Insider Initial Statement of Ownership

Page 19 of 50 · 996 filings